Viveve Medical Inc EV/EBIT
¿Qué es el EV/EBIT de Viveve Medical Inc?
El EV/EBIT de Viveve Medical Inc es N/A
¿Cuál es la definición de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de compañías en Sector Health Care en NASDAQ en comparadas con Viveve Medical Inc
¿Qué hace Viveve Medical Inc?
viveve provides women low risk, high reward medical procedures that promote personal health and wellness. the company is committed to innovative technological advances and to broad and elucidating education for medical and lay audiences worldwide.
Empresas con ev/ebit similar a Viveve Medical Inc
- Digital Landscape tiene EV/EBIT de N/A
- Immunome tiene EV/EBIT de N/A
- Royal BAM Groep NV tiene EV/EBIT de N/A
- CURO Corp tiene EV/EBIT de N/A
- Adial Pharmaceuticals tiene EV/EBIT de N/A
- NuZee tiene EV/EBIT de N/A
- Viveve Medical Inc tiene EV/EBIT de N/A
- Syros Pharmaceuticals tiene EV/EBIT de N/A
- Minerva Intelligence tiene EV/EBIT de N/A
- windeln.de SE tiene EV/EBIT de N/A
- Smith Micro Software tiene EV/EBIT de N/A
- Viaan Industries tiene EV/EBIT de N/A
- Lantern Pharma tiene EV/EBIT de N/A